Specific in vivo binding to the norepinephrine transporter demonstrated with the PET radioligand, (S,S)-[11C]MeNER

Nuclear Medicine and Biology

Volumn 30, Issue 7, 2003, Pages 707-714

  Schou, Magnus ^a   Halldin, Christer ^a   Sóvágó, Judit ^a   Pike, Victor W ^b   Gulyás, Balázs ^a   Mozley, P David ^c   Johnson, David P ^c   Hall, Håkan ^a   Innis, Robert B ^b   Farde, Lars ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^c ELI LILLY AND COMPANY   (United States)

Author keywords

Autoradiography; MeNER; Monkey; Norepinephrine transporter; PET

Indexed keywords

2 [ALPHA (2 METHOXYPHENOXY)BENZYL]MORPHOLINE C 11; DESIPRAMINE; METHYL IODIDE; NORADRENALIN TRANSPORTER; RADIOLIGAND; REBOXETINE; TRIFLUOROMETHANESULFONIC ACID; TRIFLUOROMETHANESULFONIC ACID METHYL ESTER; UNCLASSIFIED DRUG;

ARTICLE; AUTORADIOGRAPHY; BINDING AFFINITY; BRAIN LEVEL; BRAIN STEM; BRAIN TISSUE; CONTROLLED STUDY; CORPUS STRIATUM; DRUG BINDING; DRUG PURIFICATION; DRUG SPECIFICITY; ENANTIOMER; HUMAN; HUMAN TISSUE; IN VIVO STUDY; ISOTOPE LABELING; LOCUS CERULEUS; MESENCEPHALON; METHYLATION; MONKEY; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRECURSOR; PROTEIN DETERMINATION; RADIOACTIVITY; THALAMUS;

EID: 10744228667     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8051(03)00079-9     Document Type: Article

References (32)

1. Blakely R.D., De Felice L.J., Hartzell H.C. Molecular physiology of norepinephrine and serotonin transporters. J Exp Biol. 196:1994;263-281.
2. 3H]Desipramine-binding sites in human postmortem brain tissue. Neuropsychobiology. 23:1990;68-73.
3. 3H]Nisoxetine binding sites in the cat brain an autoradiographic study . Neuroscience. 69:1995;259-270.
4. Chumpradit S., Kung M.-P., Panyachotipun C., Prapansiri V., Foulun C., Brooks B.P., Szabo S.A., Tejani-Butt S.A., Frazer A., Kung H.F. Iodinated tomoxetine derivatives as selective ligands for serotonin and norepinephrine uptake sites. J Med Chem. 35:1992;4492-4497.
5. 3H]mazindol autoradiography. J Comp Neurol. 304:1991;419-434.
6. Galli A., DeFelice L.J., Duke B.-J., Moore K.R., Blakely R.D. Sodium-dependent norepinephrine-induced currents in norepinephrine-transporter-transfected HEK-293 cells blocked by cocaine and antidepressants. J Exp Biol. 198:1995;2197-2212.
7. Gehlert D.R., Schober D.A., Hemrick-Luecke S.K., Krushinski J., Howbert J.J., Robertson D.W., Fuller R.W., Wong D.T. Novel halogenated analogs of tomoxetine that are potent and selective inhibitors of norepinephrine uptake in brain. Neurochem Int. 26:1995;47-52.
8. 3H]desmethylimipramine binding in the human brain postmortem. Brain Res. 456:1988;120-126.
9. 11C]nisoxetine, a norepinephrine transporter inhibitor. Nucl Med Biol. 16:1989;771-774.
10. Hall H., Halldin C., Farde L., Sedvall G. Whole hemisphere autoradiography of the postmortem human brain. Nucl Med Biol. 25:1998;715-719.
11. Halldin C., Swahn C.-G., Farde L., Sedvall G. Radioligand disposition and metabolism. Comar D. PET for drug development and evaluation. 1995;55-65 Kluwer Academic Publishers.
12. Halldin C., Guilloteau D., Okubo Y., Lundkvist C., Olsson H., Karlsson P., Chalon S., Emond P., Swahn C.-G., Farde L. PET-characterization of [C-11]PE2I binding to dopamine receptors in the monkey brain. J Nucl Med. 39:1998;118.
13. Hara K., Yanagihara N., Minami K., Ueno S., Toyohira Y., Sata T., Kawamura M., Brüss M., Bönisch H., Shigematsu A., Izumi F. Ketamine interacts with the noradrenaline transporter at a site partly overlapping with the desipramine binding site. Naunyn-Schmied Arch Pharmacol. 358:1998;328-333.
14. 11C]NNC 756 as new radioligands for the D1-Dopamine receptor. Psychopharmacology. 113:1993;149-156.
15. Klimek V., Stockmeier C., Overholser J., Meltzer H.Y., Kalka S., Dilley G., Ordway G.A. Reduced levels of norepinephrine transporters in the locus coeruleus in major depression. J Neuroscience. 17:1997;8451-8458.
16. Melloni P., Carniel G., Della Torre G., Bonsignori A., Buonamici M., Pozzi O., Ricciardi S., Rossi A.C. Potential antidepressant agents α-aryloxy-benzyl derivatives of ethanolamine and morpholine. Eur J Med Chem Chim Ther. 19:1984;235-242.
17. Log P was predicted with the Pallas 3.0 for Windows software.
18. 123I]-2β-carbomethoxy-3β-(4-iodophenyl)tropane: high-affinity SPECT radiotracer of monoamine reuptake sites in brain. J Med Chem. 34:1991;3144-3146.
19. Ordway G.A., Stockmeyer C.A., Mason G.W., Klimek V. Pharmacology and distribution of norepinephrine transporters in the human locus coeruleus and raphe nuclei. J Neuroscience. 17:1997;1710-1719.
20. Oya S., Choi S.-R., Hou C., Mu M., Kung M.-p, Acton P.D., Stalino M., Kung H.F. 2-((2-((Dimethylamino)methyl)phenyl)thio)-5-iodophenylamine (ADAM): an improved serotonin transporter ligand. Nucl Med Biol. 27:2000;249-254.
21. Roland P.E., Graufelds C.J., Wählin J., Ingelman L., Andersson M., Ledberg A., Pedersen J., Åkerman S., Dabringhaus A., Zilles K. Human brain atlas: for high-resolution functional and anatomical mapping. Human Brain Mapping. 1:1994;173-184.
22. 11C]FLB 457 by use of the GE medical systems PETtrace MeI MicroLab. J Labelled Compd Radiopharm. 43:2000;331-338.
23. Schou M., Halldin C., Pike V., Sovago J., Gulyas B., Innis B., Farde L. Development of PET radioligands for the norepinephrine transporter. Eur J Nucl Med Mol Imaging. 29:2000;S59.
24. 3H]Nisoxetine: A radioligand for quantitation of norepinephrine uptake sites by autoradiography or by homogenate binding. J Pharm Exp Ther. 260:1992;427-436.
25. Tarkiainen J., Vercouillie J., Emond P., Sandell J., Hiltunen J., Frangin Y., Guilloteau D., Halldin C. Carbon-11 Labelling of MADAM in two different positions: a highly selective PET radioligand for the serotonin transporter. J Labelled Compd Radiopharm. 44:2001;1013-1023.
26. Kryu K., Minami K., Yanagihara N., Hara K., Tojohira Y., Izumi F., Shigematsu A. Inhibition by neuromuscular blocking drugs of norepinephrine transporter in cultured bovine adrenal medullary cells. Anaesth Analg. 91:2000;546-551.
27. 11C-labeled desipramine and its metabolite 2-hydroxydesipramine: potential radiotracers for PET studies of the norepinephrine transporter. Nucl Med Biol 2000;24:707-11.
28. Wienhard K., Dahlbom M., Eriksson L., Michel C., Bruckbauer T., Pietrzyk U., Heiss W. J Comput Assist Tomogr. 18:1994;110.
29. Wilson A.A., Johnson D.P., Mosley P.D., Hussey D., Ginovart N., Houle S. Development of a radiotracer for in vivo imaging of the norepinephrine tranporter. 2002;Neuroreceptor Mapping, Oxford, UK.
30. 11C]-DASB: a probe for in vivo measurement of the serotonin transporter by positron emission tomography. Nucl Med Biol. 29:2002;509-515.
31. Wong E.H., Sonders M.S., Amara S.G., Tinholt P.M., Piercey M.F., Hoffmann W.P., Hyslop D.K., Franklin S., Porsolt R.D., Bonsignori A., Carfagna N., McArthur R.A. Reboxetine a pharmacologically potent, selective, and specific norepinephrine reuptake inhibitor . Biol Psychiatry. 47:2000;818-829.
32. Öhman D., Norlander B., Peterson C., Bengtsson F. Bioanalysis of racemic reboxetine and its desethylated metabolite in a therapeutic drug monitoring setting using solid phase extraction and HPLC. Ther Drug Monit. 23:2001;27-34.